ArticleOncogenesis2020

MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.

DongDong Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.